Cargando…
How to Investigate a Serious Adverse Event Reported During a Clinical Trial for a COVID-19 Vaccine
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7680067/ https://www.ncbi.nlm.nih.gov/pubmed/33219926 http://dx.doi.org/10.1007/s40264-020-01018-y |
_version_ | 1783612388955652096 |
---|---|
author | Shakir, Saad Lane, Samantha Davies, Miranda |
author_facet | Shakir, Saad Lane, Samantha Davies, Miranda |
author_sort | Shakir, Saad |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7680067 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-76800672020-11-23 How to Investigate a Serious Adverse Event Reported During a Clinical Trial for a COVID-19 Vaccine Shakir, Saad Lane, Samantha Davies, Miranda Drug Saf Editorial Springer International Publishing 2020-11-21 2021 /pmc/articles/PMC7680067/ /pubmed/33219926 http://dx.doi.org/10.1007/s40264-020-01018-y Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/. |
spellingShingle | Editorial Shakir, Saad Lane, Samantha Davies, Miranda How to Investigate a Serious Adverse Event Reported During a Clinical Trial for a COVID-19 Vaccine |
title | How to Investigate a Serious Adverse Event Reported During a Clinical Trial for a COVID-19 Vaccine |
title_full | How to Investigate a Serious Adverse Event Reported During a Clinical Trial for a COVID-19 Vaccine |
title_fullStr | How to Investigate a Serious Adverse Event Reported During a Clinical Trial for a COVID-19 Vaccine |
title_full_unstemmed | How to Investigate a Serious Adverse Event Reported During a Clinical Trial for a COVID-19 Vaccine |
title_short | How to Investigate a Serious Adverse Event Reported During a Clinical Trial for a COVID-19 Vaccine |
title_sort | how to investigate a serious adverse event reported during a clinical trial for a covid-19 vaccine |
topic | Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7680067/ https://www.ncbi.nlm.nih.gov/pubmed/33219926 http://dx.doi.org/10.1007/s40264-020-01018-y |
work_keys_str_mv | AT shakirsaad howtoinvestigateaseriousadverseeventreportedduringaclinicaltrialforacovid19vaccine AT lanesamantha howtoinvestigateaseriousadverseeventreportedduringaclinicaltrialforacovid19vaccine AT daviesmiranda howtoinvestigateaseriousadverseeventreportedduringaclinicaltrialforacovid19vaccine |